New Substance Use Resource Center Made Possible by Blue Cross and Blue...

Furthering its commitment to address the opioid epidemic and fight substance abuse in local communities, Highmark Blue Cross Blue Shield West Virginia announced that a new Substance Use Resource...(PRWeb January 30, 2020)Read the full story at https://www.prweb.com/releases/new_substance_use_resource_center_made_possible_by_blue_cross_and_blue_shield_companies_aims_to_make_local_resources_accessible_to_all/prweb16874547.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news

Related Links:

Jeffrey A. SingerIn order to facilitate social distancing among people in treatment for opioid use disorder, the Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration relaxed some onerous regulations surrounding the use of buprenorphine or methadone in Medication Assisted Treatment.For health care providers to prescribe buprenorphine on an ambulatory setting to patients with addiction, they must apply for an “X waiver” on the narcotics prescribing license they get from the DEA. This is an onerous process that has resulted in a paltry...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
As the coronavirus epidemic forces many to stay home, telehealth treatment for substance abuse becomes necessary to deliver care to those who need it. Highlights a new virtual care system that utilizes video conferencing to allow patients to receive counseling in their own home and discusses how rural providers can receive virtual training through a hub-and-spoke model.
Source: News stories via the Rural Assistance Center - Category: Rural Health Source Type: news
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 3/20/2020. This one-page document offers considerations for behavioral healthcare facilities aimed at decreasing the likelihood of COVID-19 infection and viral transmission, and providing for the behavioral health needs of patients. It strongly recommends the use of telehealth and/or telephonic services to provide evaluation and treatment of patients. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 3/19/2020. The COVID-19 (coronavirus) epidemic has created countless primary and secondary challenges for those delivering care to the most vulnerable populations. An additional concern has arisen for those with alcohol use disorder, benzodiazepine use disorder, or other conditions that increase the risk of seizures. This five-page document offers precautionary guidance to those that are prepared and capable to receive and treat these individuals. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 3/19/2020. This two-page document provides answers to frequently asked questions about providing methadone and buprenorphine for the treatment of opioid use disorder during the COVID-19 (coronavirus) epidemic. Topics include the use of telehealth for new and existing patients, and dispensing medication based on telehealth. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news
North America remains in the midst of an escalating opioid overdose epidemic, largely driven by the influx of synthetic opioids such a fentanyl and related analogues. High rates of mental illness among substan...
Source: Substance Abuse Treatment, Prevention, and Policy - Category: Addiction Authors: Tags: Commentary Source Type: research
ConclusionThese results highlight the importance of knowing which factors influence TST results, such as HIV status, substance abuse or age, thus improving its usefulness as a screening method for LTBI.
Source: The Clinical Respiratory Journal - Category: Respiratory Medicine Authors: Tags: ORIGINAL ARTICLE Source Type: research
While there has been extensive attention to the ‘demand side’ – or use and adverse consequences, including mortality – of the ‘opioid crisis’ presently unfolding across North America, few considerations have f...
Source: Substance Abuse Treatment, Prevention, and Policy - Category: Addiction Authors: Tags: Commentary Source Type: research
State governments in the United States are increasingly viewing marijuana legalization as a policy option for controlling the opioid epidemic under the premise that marijuana is a less harmful substitute for o...
Source: Substance Abuse Treatment, Prevention, and Policy - Category: Addiction Authors: Tags: Research Source Type: research
New largescale study in the American Journal of Preventive Medicine found overprescription of opioids by dentists common, particularly to patients at high risk for substance abuse, and that almost 1/3 of patients received more powerful drugs than neededElsevierIMAGE: In this cross-sectional analysis of 542,958 dental visits by adult patients, between 1 in 4 and 1 in 2 opioid prescriptions exceeded the recommended morphine equivalents and days'supply for...viewmore Credit: Michelle S. Woods Ann Arbor, February 4, 2020 - Dentists are among top prescribers of opioids in the US, however, whether their opioid prescrib...
Source: Dental Technology Blog - Category: Dentistry Source Type: news
More News: Epidemics | Epidemiology | Pharmaceuticals | Substance Abuse | Substance Abuse Disorders